A 5-Year Open-Label Follow-up of a Randomized Double-Blind Placebo-Controlled Trial of Intralymphatic Immunotherapy for Birch and Grass Allergy Reveals Long-term Beneficial Effects
1. 系统已在2026-05-29 10:56:31对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.18176/jiaci.0832
文献链接: https://www.jiaci.org/summary/vol33-issue5-num2758
其他信息:
出版社: Esmon Publicidad, SA
作者: E Hjalmarsson; L Hellkvist; A Karlsson; O Winquist; S Kumlien Georén; U Westin; LO Cardell

